WorldCare Clinical, LLC (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology and medical device industries, today announced that Robert Fetterman has joined the organization as associate director of imaging services. In his new position, Fetterman will leverage his extensive clinical core laboratory and imaging experience to extend the usability and functionality of WCC’s cost-effective imaging transmission platform, WorldPro™.
Fetterman has more than twenty years of experience in the development and management of imaging trial processes in clinical, academic core, and industry laboratories. His background includes clinical oncologic and cardiovascular imaging, cardiovascular imaging software development, and the implementation and management of multimodality, remote and electronic blinded review systems for imaging trials.
“Bob’s understanding and perspective as an end-user, coupled with his experience in software development, uniquely position him to have a significant impact on our operational efficiency and allows us to better anticipate the needs of our clients,” said WCC Managing Director Michael O’Brien.
Prior to joining WCC, Fetterman was associate director of imaging science at Acusphere Inc., where he was responsible for the development and implementation of digital imaging and video processing systems for preclinical use, and image review systems for clinical trial use in echocardiology. He was previously a software developer and imaging science manager for the Yale Nuclear Cardiology Exercise and Imaging Laboratory, and creator and manager of Yale University’s TIMI Core Laboratory for the first six NHLBI-sponsored TIMI trials. Fetterman holds a bachelor’s degree in computer science and an associate’s degree in nuclear medicine technology from University of Vermont.